Recommendations | AACE/AME/ETA (2010) | ATA (2009) | BTA (2007) | ESMO (2012) | GAES (2013) | IKNL (2007) | LATS (2009) | NCCN (2013) | NCN (2000) | SEOM (2011) |
---|---|---|---|---|---|---|---|---|---|---|
Diagnosis | ||||||||||
Indications of fine-needle aspiration (without suspicions) | n >1 cm | n >0.5 cm | n >0.5 cm | n >1 cm | All nodules | All nodules | N/A | n >1.5 cm | All nodules | n >1 cm |
Routine serum calcitonin | Optional | NR | N/A | R | R | R | Optional | Optional | Optional | R |
Thyroid scan | Low TSH | Follicular lesion with low TSH | N/A | Unclear | Before operation | NR | N/A | Follicular lesion with low TSH | Unclear | NR |
Treatment | ||||||||||
Indication of total thyroidectomy for DTC | N/A | n >1 cm | n >1 cm | n >1 cm | n >1 cm | n >1 cm | All sizes | n >4 cm | n >1 cm | n >4 cm |
Cervical lymph node dissection (node negative) | N/A | n >4 cm | n >4 cm/male/age >45 years | Optional | Optional | N/A | n >4 cm | Optional | Unclear | Optional |
Postoperative care | ||||||||||
Indication of I131 ablation | N/A | n >4 cm/high-risk patients | High-risk patients | n >2 cm/high-risk patients | N/A | High-risk patients | High-risk patients | Tg >1 ng/ml/high-risk patients | n >1 cm | High-risk patients |
Target level of TSH suppression therapy (mU/L) | ||||||||||
High risk | N/A | <0.1 | <0.1 | <0.1 | N/A | <0.1 | <0.1 | <0.1 | 0.01 to 0.1 | <0.1 |
Low risk | N/A | 0.1 to 0.5 | 0.1 to 0.5 | WNL | N/A | 0.4 to 1.0 | Close to the lower limit | <0.1 to 0.5 |